GARNET BIOTHERAPEUTICS INC has a total of 50 patent applications. Its first patent ever was published in 2002. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are AVONTEC GMBH, COLEY PHARM GMBH and IDERA PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Australia | 5 | |
#3 | Canada | 5 | |
#4 | EPO (European Patent Office) | 5 | |
#5 | Mexico | 4 | |
#6 | WIPO (World Intellectual Property Organization) | 4 | |
#7 | Israel | 3 | |
#8 | Singapore | 3 | |
#9 | China | 2 | |
#10 | Hong Kong | 2 | |
#11 | Japan | 2 | |
#12 | New Zealand | 2 | |
#13 | South Africa | 2 | |
#14 | African Regional Industrial Property Organization | 1 | |
#15 | Brazil | 1 | |
#16 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Organic fine chemistry | |
#5 | Environmental technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Fermentation | |
#5 | Analysing materials | |
#6 | Sugars | |
#7 | Climate change adaptation technologies |
# | Name | Total Patents |
---|---|---|
#1 | Ragaglia Vanessa | 45 |
#2 | Kopen Gene | 21 |
#3 | Wagner Joseph | 16 |
#4 | Sharma Vandana Madanlal | 14 |
#5 | Brayfield Candace | 10 |
#6 | Heimbach Baron | 10 |
#7 | Gore Richard S | 9 |
#8 | Righter William F | 6 |
#9 | Rutkowski J Lynn | 6 |
#10 | Kopen Gene C | 6 |
Publication | Filing date | Title |
---|---|---|
WO2014143871A2 | Thermoresponsive polymer applications for adherent cell culture and recovery | |
CN105142645A | Ganglioside compositions | |
AU2013202319A1 | Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro | |
WO2013109929A1 | Methods of ganglioside production | |
AU2011257970A1 | Compositions and methods of using living and non-living bioactive devices with components derived from self- renewing colony forming cells cultured and expanded in vitro | |
HK1143181A1 | Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro | |
BRPI0813905A2 | Treatment of diseases and disorders using cultivated and expanded in vitro self-cultivated colony forming cells | |
NZ582616A | Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro |